Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A condition caused by infection by the Venezuelan equine encephalitis virus, which is characterized by headache, fever, myalgia, nausea, and vomiting.
Biomarker and diagnostic research for Venezuelan equine encephalitis has been reported in the published literature.
1 clinical trial registered. Interventions under study include biologic therapy. Pipeline includes 1 PHASE1. Research is primarily industry-sponsored.
188 publications have been identified in PubMed for Venezuelan equine encephalitis. Research spans Basic Science / Preclinical (38%), Review / Meta-Analysis (27%), and Gene Therapy / Novel Therapeutics (15%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 57 | 38% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:55 PM UTC
Genetic and Rare Diseases Info Center
Common questions about Venezuelan equine encephalitis
Research summaries |
41 |
27% |
New treatment approaches | 23 | 15% |
Disease patterns and progression | 18 | 12% |
Testing and diagnosis research | 6 | 4% |
Patient case studies | 4 | 3% |
Clinical study results | 2 | 1% |
Other research | 1 | 1% |
VanderGiessen M (2026). [PMID: 41950299](https://pubmed.ncbi.nlm.nih.gov/41950299/). *PLoS Pathog*. [Basic Science / Preclinical]
LaPointe AT (2026). [PMID: 41988191](https://pubmed.ncbi.nlm.nih.gov/41988191/). *Front Immunol*. [Gene Therapy / Novel Therapeutics]
Lázár E (2026). [PMID: 41028908](https://pubmed.ncbi.nlm.nih.gov/41028908/). *Nat Rev Genet*. [Review / Meta-Analysis]
Behnia M (2026). [PMID: 42023950](https://pubmed.ncbi.nlm.nih.gov/42023950/). *J Virol*. [Basic Science / Preclinical]
Sun C (2026). [PMID: 42044145](https://pubmed.ncbi.nlm.nih.gov/42044145/). *PLoS One*. [Gene Therapy / Novel Therapeutics]
LaPointe AT (2026). [PMID: 41659433](https://pubmed.ncbi.nlm.nih.gov/41659433/). *bioRxiv : the preprint server for biology*. [Basic Science / Preclinical]
Gautam A (2026). [PMID: 42072665](https://pubmed.ncbi.nlm.nih.gov/42072665/). *Biomolecules*. [Basic Science / Preclinical]
Wong J (2026). [PMID: 41537597](https://pubmed.ncbi.nlm.nih.gov/41537597/). *Journal of virology*. [Basic Science / Preclinical]
Valero-Cedeño N (2026). [PMID: 42142379](https://pubmed.ncbi.nlm.nih.gov/42142379/). *Rev Med Virol*. [Review / Meta-Analysis]
Trefry SV (2026). [PMID: 42079289](https://pubmed.ncbi.nlm.nih.gov/42079289/). *bioRxiv*. [Basic Science / Preclinical]